Applications
Application Search for UHPLC & HPLC
| Classification | Data name | Compound name | Product code | Column | |
| Pharmaceuticals, Drugs, Metabolites | Butenafine hydrochloride solution and spray and cream | Diphenyl (I.S.) Butenafine hydrochloride | OS12S03-0503WT | YMC-Pack Pro C8 | |
| Pharmaceuticals, Drugs, Metabolites | Lansoprazole | Lansoprazole | KSA99S05-2546WT | CHIRAL ART Amylose-SA | |
| Pharmaceuticals, Drugs, Metabolites | Butenafine hydrochloride | Butenafine hydrochloride | TA12S03-1503WT | YMC-Triart C18 | |
| Pharmaceuticals, Drugs, Metabolites | Rabeprazole | Rabeprazole | KSC99S05-2546WT | CHIRAL ART Cellulose-SC | |
| Pharmaceuticals, Drugs, Metabolites | Analysis of Remdesivir and active metabolite GS-441524 using YMC-Triart C18 | Remdesivir GS-441524 | TA12SP9-05Q1PT | YMC-Triart C18 | |
| Pharmaceuticals, Drugs, Metabolites | Amoxicillin | Amoxicillin Caffeine | HS12S05-1546WT | Hydrosphere C18 | |
| Pharmaceuticals, Drugs, Metabolites | Ofloxacin | (S)-(-)-Ofloxacin (Levofloxacin) (R)-(+)-Olfoxacin | KSC99S05-2546WT | CHIRAL ART Cellulose-SC | |
| Pharmaceuticals, Drugs, Metabolites | Analysis of Bevacizumab (Avastin®) by YMC-SEC-MAB and MALLS | Bevacizumab (Avastin®) | DLM25S03-3046WT | YMC-SEC MAB | |
| Pharmaceuticals, Drugs, Metabolites | Cephalosporin C | Cephalosporin C potassium Resorcinol | HS12S05-1546WT | Hydrosphere C18 | |
| Pharmaceuticals, Drugs, Metabolites | Polaprezinc (JP 17th|Assay) | L-Histidine L-Carnosine | TA12S05-1546PTH | YMC-Triart C18 | |
| Pharmaceuticals, Drugs, Metabolites | Cephalosporin antibiotics | Cephalexin Cefaclor Cephaloglycin Cephaloridine | HS12S05-1546WT | Hydrosphere C18 | |
| Pharmaceuticals, Drugs, Metabolites | Polaprezinc Granules (JP 17th|Assay) | L-Carnosine | TA12S05-1546PTH | YMC-Triart C18 | |
| Pharmaceuticals, Drugs, Metabolites | Ceftriaxone | Ceftriaxone sodium Phenol | HS12S05-1546WT | Hydrosphere C18 | |
| Pharmaceuticals, Drugs, Metabolites | Vancomycin | Vancomycin hydrochloride 4'-Hydroxyacetophenone | HS12S05-1546WT | Hydrosphere C18 | |
| Pharmaceuticals, Drugs, Metabolites | Clopidogrel Sulfate (JP draft) | Clopidogrel sulfate | AS12S05-1504WT | YMC-Pack Pro C18 | |
| Pharmaceuticals, Drugs, Metabolites | Nafamostat and its metabolites | Nafamostat mesilate p-Guanidinobenzoic acid hydrochloride 6-Amidino-2-naphthol hydrochloride | TA12SP9-05Q1PT | YMC-Triart C18 | |
| Pharmaceuticals, Drugs, Metabolites | Clopidogrel Sulfate Tablets (JP draft) | Isopropyl benzoate (I.S.) Clopidogrel sulfate | AS12S05-1504WT | YMC-Pack Pro C18 | |
| Pharmaceuticals, Drugs, Metabolites | Separation of 11 common cannabinoids | Cannabivarin (CBV) Cannabidiolic acid (CBDA) Cannabigerol (CBG) Cannabidiol (CBD) Tetrahydrocannabivarin (THCV) Cannabinol (CBN) Delta-9-tetrahydrocannabinol (Δ9-THC) Delta-8-tetrahydrocannabinol (Δ8-THC) Cannabicyclol (CBL) Cannabichromene (CBC) Tetrahydrocannabinolic acid (THCA) | TA12S03-1546PTH | YMC-Triart C18 | |
| Pharmaceuticals, Drugs, Metabolites | Steroids from toad venom | Bufalin Cinobufagin Resibufogenin Indomethacin | AL12S05-1546WT | YMC-Pack ODS-AL | |
| Pharmaceuticals, Drugs, Metabolites | Montelukast sodium tablets (JP draft | Dissolution) | Montelukast | PH12S05-1003WT | YMC-Pack Phenyl |
